Pierre A. Morgon
CEO - MRGN Advisors
Regional Partner Switzerland- Merieux Equity Partners
Switzerland
Biography
Pierre A Morgon is the CEO of MRGN Advisors and Regional Partner for Switzerland at Merieux Developpement. He is also Chairman of the Board of Virometix, as well as Non-Executive Director to the Boards of Theradiag, of Eurocine Vaccines and of Vaccitech. He has over 30 years of experience in the global Life Science industry, especially with vaccines and immunotherapy, at the HELM of international operations, in C-level positions at global level and as CEO of start-ups. He is a Lecturer in several MBA programs in world-class business schools and in Life Science conferences, as well as to the MassChallenge biotechnology incubator in Switzerland. He holds a Doctorate of Pharmacy, Master of Business Law and an MBA. He is also an Alumnus of INSEAD and IMD.
Research Interest
Pharmaceutical, biological industry and in healthcare